Neurobehavioral burden of multiple sclerosis with nanotheranostics
Bhasker Sriramoju, Rupinder K Kanwar, Jagat R Kanwar Nanomedicine-Laboratory of Immunology and Molecular Biomedical Research (NLIMBR), School of Medicine, Molecular and Medical Research, Faculty of Health, Deakin University, VIC, Australia Abstract: Multiple sclerosis (MS) is a chronic demyelinati...
Guardado en:
Autores principales: | Sriramoju B, Kanwar RK, Kanwar JR |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8061bea6a1dd4d9f9fd5bc99ab872cf6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
por: Babij R, et al.
Publicado: (2015) -
Association between smoking and cognitive impairment in multiple sclerosis
por: Özcan ME, et al.
Publicado: (2014) -
Cognitive dysfunction in pediatric multiple sclerosis
por: Suppiej A, et al.
Publicado: (2014) -
The Multiple Sclerosis Treatment Optimization Program
por: Annette Langer‐Gould, et al.
Publicado: (2021) -
Role of oral teriflunomide in the management of multiple sclerosis
por: Tanasescu R, et al.
Publicado: (2013)